WO2009098404A8 - Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation - Google Patents
Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation Download PDFInfo
- Publication number
- WO2009098404A8 WO2009098404A8 PCT/FR2008/001661 FR2008001661W WO2009098404A8 WO 2009098404 A8 WO2009098404 A8 WO 2009098404A8 FR 2008001661 W FR2008001661 W FR 2008001661W WO 2009098404 A8 WO2009098404 A8 WO 2009098404A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- macromolecules
- amphiphilic molecules
- nanoparticles based
- preparing nanoparticles
- functional amphiphilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/745,670 US20110059180A1 (en) | 2007-11-30 | 2008-11-28 | Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof |
CA2706812A CA2706812A1 (fr) | 2007-11-30 | 2008-11-28 | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation |
CN2008801260085A CN101932310B (zh) | 2007-11-30 | 2008-11-28 | 制备基于官能两亲分子或者大分子的纳米颗粒的方法和其用途 |
JP2010535425A JP5719594B2 (ja) | 2007-11-30 | 2008-11-28 | 機能性両親媒性の分子又は巨大分子を基とするナノ粒子の調製方法及びその使用 |
EP08872219A EP2231132A2 (fr) | 2007-11-30 | 2008-11-28 | Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation |
US14/208,978 US9533049B2 (en) | 2007-11-30 | 2014-03-13 | Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR07/08399 | 2007-11-30 | ||
FR0708399A FR2924430B1 (fr) | 2007-11-30 | 2007-11-30 | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/745,670 A-371-Of-International US20110059180A1 (en) | 2007-11-30 | 2008-11-28 | Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof |
US14/208,978 Division US9533049B2 (en) | 2007-11-30 | 2014-03-13 | Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2009098404A2 WO2009098404A2 (fr) | 2009-08-13 |
WO2009098404A3 WO2009098404A3 (fr) | 2009-11-12 |
WO2009098404A8 true WO2009098404A8 (fr) | 2010-01-28 |
Family
ID=39638675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2008/001661 WO2009098404A2 (fr) | 2007-11-30 | 2008-11-28 | Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation |
Country Status (7)
Country | Link |
---|---|
US (2) | US20110059180A1 (fr) |
EP (1) | EP2231132A2 (fr) |
JP (3) | JP5719594B2 (fr) |
CN (1) | CN101932310B (fr) |
CA (1) | CA2706812A1 (fr) |
FR (1) | FR2924430B1 (fr) |
WO (1) | WO2009098404A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2945946B1 (fr) * | 2009-05-29 | 2011-08-26 | Univ Victor Segalen Bordeaux 2 | Formulations a compartiments multiples a base de molecules ou macromolecules amphiphiles fonctionnelles |
EP3085360A1 (fr) | 2015-04-20 | 2016-10-26 | Universite De Bordeaux | Compositions de nanovecteurs à base de lipide chargées avec des nanoparticules métalliques et agent thérapeutique |
JP2019532027A (ja) | 2016-08-17 | 2019-11-07 | ソルスティス バイオロジクス,リミティッド | ポリヌクレオチド構築物 |
WO2019006455A1 (fr) | 2017-06-30 | 2019-01-03 | Solstice Biologics, Ltd. | Auxiliaires de phosphoramidites chiraux et leurs procédés d'utilisation |
EP3502684A1 (fr) | 2017-12-22 | 2019-06-26 | Universite De Bordeaux | Procédé de détection d'ions métalliques dans des solutions aqueuses au moyen de composés nucléolipides |
EP3505178A1 (fr) | 2017-12-29 | 2019-07-03 | Universite De Bordeaux | Formulations de gel de bio-encres comprenant un composé à base de nucléolipides |
FR3078064A1 (fr) | 2018-02-22 | 2019-08-23 | Universite de Bordeaux | Procede de decontamination d'un milieu liquide aqueux contenant des micropolluants |
CA3150779A1 (fr) * | 2019-08-12 | 2021-02-18 | Integrated Nanotherapeutics Inc. | Lipides pour l'administration d'un materiau charge, leurs formulations et leur procede de fabrication |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0696590B2 (ja) * | 1985-04-16 | 1994-11-30 | 富山化学工業株式会社 | 新規な5−フルオロ−2′−デオキシウリジン−3′−ホスフエ−ト誘導体およびその塩 |
DK86988A (da) * | 1987-02-25 | 1988-08-26 | Takeda Chemical Industries Ltd | Liposompraeparat og anvendelse deraf |
US6001817A (en) * | 1998-01-12 | 1999-12-14 | Unitech Pharmaceuticals, Inc. | Pharmaceutical composition comprised of cisplatin, and processes for making and using same |
GB9813535D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
AU2158401A (en) * | 1999-11-05 | 2001-05-14 | Seed Capital Investments-2 (Sci-2) B.V. | Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
AU2002359918A1 (en) * | 2001-12-28 | 2003-07-24 | Terumo Kabushiki Kaisha | Blood bag system and method of inactivating pathogenic microorganisms |
FR2869616B1 (fr) * | 2004-04-29 | 2008-10-24 | Univ D Avignon Et Des Pays Du | Nouveaux composes amphiphiles, leur procede de preparation et leurs applications notamment a la transfection |
CN103735560A (zh) * | 2005-06-07 | 2014-04-23 | 耶鲁大学 | 使用克来夫定和替比夫定治疗癌症和其它病症或疾病状态的方法 |
FR2945946B1 (fr) * | 2009-05-29 | 2011-08-26 | Univ Victor Segalen Bordeaux 2 | Formulations a compartiments multiples a base de molecules ou macromolecules amphiphiles fonctionnelles |
-
2007
- 2007-11-30 FR FR0708399A patent/FR2924430B1/fr not_active Expired - Fee Related
-
2008
- 2008-11-28 CN CN2008801260085A patent/CN101932310B/zh not_active Expired - Fee Related
- 2008-11-28 EP EP08872219A patent/EP2231132A2/fr not_active Withdrawn
- 2008-11-28 US US12/745,670 patent/US20110059180A1/en not_active Abandoned
- 2008-11-28 JP JP2010535425A patent/JP5719594B2/ja not_active Expired - Fee Related
- 2008-11-28 CA CA2706812A patent/CA2706812A1/fr not_active Abandoned
- 2008-11-28 WO PCT/FR2008/001661 patent/WO2009098404A2/fr active Application Filing
-
2014
- 2014-03-13 US US14/208,978 patent/US9533049B2/en not_active Expired - Fee Related
- 2014-09-29 JP JP2014198816A patent/JP2015044815A/ja active Pending
-
2016
- 2016-07-29 JP JP2016149551A patent/JP6280167B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2011504920A (ja) | 2011-02-17 |
FR2924430A1 (fr) | 2009-06-05 |
JP2017014243A (ja) | 2017-01-19 |
JP5719594B2 (ja) | 2015-05-20 |
JP2015044815A (ja) | 2015-03-12 |
WO2009098404A3 (fr) | 2009-11-12 |
CA2706812A1 (fr) | 2009-08-13 |
CN101932310A (zh) | 2010-12-29 |
JP6280167B2 (ja) | 2018-02-14 |
US20110059180A1 (en) | 2011-03-10 |
US9533049B2 (en) | 2017-01-03 |
FR2924430B1 (fr) | 2010-03-19 |
CN101932310B (zh) | 2013-11-13 |
EP2231132A2 (fr) | 2010-09-29 |
US20140308343A1 (en) | 2014-10-16 |
WO2009098404A2 (fr) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009098404A3 (fr) | Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation | |
CY1116622T1 (el) | Αντισωματα anti-cd22, τα ανοσοσυζευγματα τους και χρησεις αυτων | |
SI1909843T1 (sl) | Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju | |
WO2009120247A3 (fr) | Compositions de nanoparticules de lipides et procédés de préparation et d’utilisation de celles-ci | |
WO2010069532A8 (fr) | Anticorps dirigés contre l'angiopoïétine 2 humaine | |
WO2008030211A3 (fr) | Procédés de fabrication d'une dispersion de nanomatériaux et produits issus de celle-ci | |
DK1943016T3 (da) | Kompositnanopartikler, nanopartikler og fremgangsmåder til fremstilling heraf | |
WO2007118653A3 (fr) | Nanoparticules contenant de la nicotine et/ou de la cotinine, dispersions et leur utilisation | |
WO2010013224A3 (fr) | Nanoparticules de curcumine et leurs procédés de production | |
WO2007047498A3 (fr) | Formation et encapsulation de membranes moleculaires monocouches et bicouches | |
WO2008033300A8 (fr) | Formulation de bis (thiohydrazide amides) | |
WO2008120998A3 (fr) | Particules administrant des médicaments acoustiquement sensibles | |
IL201730A (en) | History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs | |
DE602005014718D1 (de) | Aktor und Transportvorrichtung, bewegliches Gerät sowie Vorrichtung ausgestattet mit dem Aktor | |
FR2895412B1 (fr) | Procede de preparation de nanoparticules en feuillets et nanoparticules obtenues. | |
ZA201009097B (en) | C-ring-substituted pregn-4-ene-21,17-carbolactone,and pharmaceutical preparations comprising the latter | |
ATE531715T1 (de) | 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen | |
EP2266619A4 (fr) | Composition pharmaceutique à base d'hépatoprotecteur et de prébiotique, fabrication et utilisation de celle-ci | |
BRPI0812871A2 (pt) | " recipiente, e, método para formar o mesmo ". | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
WO2008110374A3 (fr) | Granulés contenant une substance pharmaceutique, procédés de fabrication et utilisation de ceux-ci | |
EP2193789A4 (fr) | Utilisation du 3,5-dihydrotoluène ou de ses dérivés dans la préparation de médicaments ou de nourriture fonctionnelle destinés au traitement ou à la prévention de la dépression | |
AP2010005435A0 (en) | 1,4-Naphthoquinone derivatives and therapeutic usethereof. | |
SG148120A1 (en) | An oral pharmaceutical and an oral care product | |
PL1835917T3 (pl) | Środki zawierające kwas foliowy, witaminę B6 i witaminę B12 oraz ich zastosowanie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880126008.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08872219 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2706812 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010535425 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4453/DELNP/2010 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008872219 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12745670 Country of ref document: US |